Global Drugs of Abuse Testing Market Opportunities & Forecast Global Drugs of Abuse Testing Market Opportunities | Page 2
specialized device, kits, and expertise. Drug of abuse testing is used
increasingly as a deterrent to illicit drug use and as an objective means to
document drug abuse among patients, job applicants, employees, athletes,
and students. Several illicit drugs such as opioids, cocaine, LSD,
amphetamines, alcohol are commonly used as the drug of abuse. According to
the CDC Wonder database, in 2017, in the United States, more than 72,000
deaths were from a drug overdose which included illicit drugs and
prescription opioids. Drug of abuse testing is routinely performed in the
healthcare facilities such as diagnostic lab, hospitals, and mobile clinics.
Request Sample Pages : https://tinyurl.com/ycxpxfat
Factors such as growing drug abuse population, increasing demand for a drug
of abuse testing from the public and the companies and rising drug-related
mortality rates are few of the factors that are driving the growth of the drug of
abuse testing market during the forecast period. In addition, rising
government programs to overcome or control the drug of abuse and rise in
government funding also act as a driver for the growth of drug of abuse
market. For instance, the US government has recently funded more than 60
inpatient and outpatient drug treatment centers across the country. In
addition, stringent laws, growing adoption of drug testing at the workplace,
and an increasing number of toxicological laboratories are some of the
factors that are anticipated to boost the market. However, legalization of
illicit drugs, social issues associated with the drug of abuse testing, inability
to detect low-dose designer drugs, and lack of a global standard definition of
a problem drug user are some of the factors which are hindering the growth of
the drugs of abuse testing market.
Various notable players operating in the market, include F. Hoffmann La-
Roche Ltd, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific,
Inc., Quest Diagnostics, Alere, Inc., Shimadzu Corporation, Drägerwerk AG &